Sign Up to like & get
recommendations!
0
Published in 2018 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2018-eular.5507
Abstract: Background: Tumor necrosis factor-a inhibitors (TNFi’s) effectively treat various autoimmune conditions, but drastically increase the risk of tuberculosis (TB) reactivation. Multiple international guidelines recommend screening for TB prior to initiating TNFi therapy. In the United…
read more here.
Keywords:
real world;
inhibitor therapy;
initiating tnfi;
united states ... See more keywords